Diablo's Delight XL Auto® by Sweet Seeds®: the perfect car
Among the new autoflowering genetics introduced in 2025, the Diablo's Delight XL Auto (SWS113) stands out for its unique lineage and aromatic complexity. This autoflowering variety combines Watermelon OG, known for its fruity and sweet profile, with Diablo Rojo XL Auto, recently awarded in the autoflowering category.
Genetic profile
Diablo's Delight XL Auto® is a 4th-generation autoflowering plant, selected for its robust development and rich aromatic expressions. The terpene profile is marked by notes of watermelon and ripe fruit, supported by light notes of citrus and earth.
- Indica : 53.4% | Sativa : 45% | Ruderalis : 1.6%
- THC: 18-24%
- CBD: 0.2
- Estimated yield :
- Indoors: 450-550 g/m².
- Outdoors: 50-175 g/plant
- Life cycle: Approximately 8 weeks from germination
- Height: 60-130 cm
In jurisdictions where cannabis cultivation is authorized, it has been observed that the Diablo's Delight XL Auto grew vigorously with a dense central cola and strong lateral branches. Some growers report significant vertical growth at the start of flowering. Due to the dense structure of the flowers, it is advisable to monitor humidity levels and air circulation to avoid moisture-related problems.
Growing methods vary considerably, but this variety seems to respond well to light, airy substrates such as coco, which encourages strong root development. Some testers report the appearance of pre-flowers around the third week, with flowering starting shortly afterwards. The flowering period is characterized by notable resin production, with trichomes spreading over calyxes and surrounding leaves.
Variations in color, such as purple hues, may appear depending on environmental factors such as temperature drops. Aromas intensify towards the end of the cycle, offering a complex bouquet that blends sweet, acidic and earthy notes.
Diablo's Delight XL Auto is thus a compelling example of the evolution of autoflowering cannabis in terms of flavour, structure and cannabinoid expression. It's an interesting collector's item for those interested in cannabis genetics, and reflects the wider shift in breeding priorities towards speed, potency and sensory complexity.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login